Modeling and analysis of PET studies with norepinephrine transporter ligands: The search for a reference region

Nuclear Medicine and Biology

Volumn 32, Issue 5, 2005, Pages 531-542

  Logan, Jean ^a   Ding, Yu Shin ^a   Lin, Kuo Shyan ^a   Pareto, Deborah ^a,b   Fowler, Joanna ^a   Biegon, Anat ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Modeling; Norepinephrine transporter; PET; Reboxetine

Indexed keywords

COCAINE; DOPAMINE; FLUOROREBOXETINE F 18; LIGAND; N NISOXETINE C 11; NISOXETINE; NORADRENALIN; O METHYLREBOXETINE C 11; O NISOXETINE C 11; RACLOPRIDE; REBOXETINE; SEROTONIN TRANSPORTER; TRACER; UNCLASSIFIED DRUG;

ARTICLE; BABOON; BASAL GANGLION; CALCULATION; CEREBELLUM; CINGULATE GYRUS; CONTROLLED STUDY; CORRELATION COEFFICIENT; DENSITY; DISTRIBUTION VOLUME; ENANTIOMER; FRONTAL CORTEX; ISOTOPE LABELING; NONHUMAN; OCCIPITAL CORTEX; POSITRON EMISSION TOMOGRAPHY; REDUCTION; REPRODUCIBILITY; THALAMUS;

ANIMALS; BRAIN; CARBON RADIOISOTOPES; FLUORINE RADIOISOTOPES; FLUOXETINE; LIGANDS; MORPHOLINES; PAPIO; POSITRON-EMISSION TOMOGRAPHY; RACLOPRIDE;

EID: 20744446933     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2005.04.005     Document Type: Article

References (42)

1. R. Blakely, and A. Bauman Biogenic amine transporters: regulation in flux Curr Opin Neurobiol 10 2000 328 336
2. N.D. Volkow, G.-J. Wang, J.S. Fowler, F. Telang, L. Maynard, and J. Logan Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain Am J Psychiatry 161 2004 1173 1180
3. N.D. Volkow, J.S. Fowler, and G.J. Wang Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans J Psychopharmacol 13 1999 337 345
4. A. Frazer Serotonergic and noradrenergic reuptake inhibitors: prediction of clinical effects from in vitro potencies J Clin Psychiatry 62 Suppl 12 2001 16 23
5. E.L. Barker, and R.D. Blakely Norepinephrine and serotonin transporters: molecular targets of antidepressant drugs F.E. Bloom D.J. Kupfer Psychopharmacology: the fourth generation of progress 1995 Raven Press New York 321 334
6. E. Carboni, and A. Silvagni Dopamine reuptake by norepinephrine neurons: exception or rule? Crit Rev Neurobiol 16 2004 121 128
7. M.F. Egan, T.E. Goldberg, B.S. Kolachana, J.H. Callicott, C.M. Mazzanti, and R.E. Straub Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia Proc Natl Acad Sci U S A 98 2001 6917 6922
8. J.A. Moron, A. Brockington, R.A. Wise, B.A. Rocha, and B.T. Hope Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines J Neurosci 22 2002 389 395
9. S. Stahl Neurotransmission of cognition: Part 1. Dopamine is a hitchhiker in frontal cortex: norepinephrine transporters regulate dopamine J Clin Psychiatry 64 2003 4 5
10. F. Bymaster, J. Katner, D. Nelson, S. Hemrick-Luecke, P. Threlkeld, and J. Heiligenstein Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder Neuropsychopharmacology 27 2002 699 711
11. 3H]desmethylimipramine binding sites in rat brain by quantitative autoradiography J Neurosci 3 1983 1069 1076
12. 3H]Nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding J Pharmacol Exp Ther 260 1992 427 436
13. Y. Charnay, L. Leger, P.G. Vallet, M. Jouvet, and C. Bouras [3H] Nisoxetine binding sites in the cat brain: an autoradiographic study Neuroscience 69 1995 259 270
14. A. Wilson, D. Johnson, D. Mozley, D. Hussey, N. Ginovart, and J. Nobrega Synthesis and in vivo evaluation of novel radiotracers for the in vivo imaging of the norepinephrine transporter Nucl Med Biol 30 2003 85 92
15. 11C]MeNER Nucl Med Biol 30 2003 707 714
16. M. Schou, C. Halldin, J. Sovago, V. Pike, H. Hall, and B. Gulyas PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain Synapse 53 2004 57 67
17. 125I]iodo-nisoxetine to norepinephrine transporters in the brain Nucl Med Biol 31 2004 533 541
18. Y. Kiyono, N. Kanegawa, H. Kawashima, Y. Kitamura, Y. Iida, and H. Saji Evaluation of radioiodinated (R)-N-methyl-3-(2-iodophenoxy)-3-phenylpropanamine as a ligand for brain norepinephrine transporter imaging Nucl Med Biol 31 2004 147 153
19. Y. Ding, K. Lin, V. Garza, P. Carter, D. Alexoff, and J. Logan Evaluation of a new norepinephrine transporter PET ligand in baboons, both in brain and peripheral organs Synapse 50 2003 345 352
20. 11C]nisoxetine, a norepinephrine uptake inhibitor Int J Radiat Appl Instrum B 16 1989 771 774
21. 3H]desipramine binding associated with neuronal norepinephrine uptake sites in rat brain membranes J Neurosci 2 1982 1515 1525
22. K. Lin, S. Kim, and Y. Ding Synthesis and evaluation of F-18 labeled reboxetine analogs as PET tracers for norepinephrine transporter J Nucl Med Suppl 2004 106
23. Y.-S. Ding, and K.-S. Lin PET imaging studies of norepinephrine transporters Presented to the 34th Annual Meeting of the Society for Neuroscience 2004
24. J. Logan Graphical analysis of PET data applied to reversible and irreversible tracers Nucl Med Biol 27 2000 661 670
25. 3 receptors in the cerebellum Brain Res 737 1996 347 350
26. 3 receptor mediated effect? Prog Neuropsychopharmacol Biol Psychiatry 24 2000 39 49
27. 3H]7-hydroxy-N,N-di-n-propyl-2-aminotetralin Brain Res 648 1994 222 228
28. 2 receptors J Pharmacol Exp Ther 291 1999 409 415
29. N.D. Volkow, R.C. Gur, G.-J. Wang, J.S. Fowler, P.J. Moberg, and Y.-.S. Ding Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals Am J Psychiatry 155 1998 344 349
30. G.-J. Wang, L. Chang, N.D. Volkow, F. Telang, J. Logan, and T. Ernst Decreased brain dopaminergic transporters in HIV-associated dementia patients Brain 127 2004 2452 2458
31. K. Lin, and Y. Ding Synthesis, enantiomeric resolution, and selective C-11 methylation of a highly selective radioligand for imaging the norepinephrine transporter with positron emission tomography Chirality 16 2004 475 481
32. Y. Ding, J. Fowler, N. Volkow, J. Logan, S. Gatley, and Y. Sugano Carbon-11-d-threo-methylphenidate binding to dopamine transporter in baboon brain J Nucl Med 36 1995 2298 2305
33. 11C-methyl]-(-)-cocaine PET studies in human subjects J Cereb Blood Flow Metab 10 1990 740 747
34. 11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data J Cereb Blood Flow Metab 14 1994 995 1010
35. 18F]FP- TZTP: control and competition studies J Cereb Blood Flow Metab 18 1998 1130 1142
36. J. Logan Strategies for quantifying PET imaging data from tracer studies of brain receptors and enzymes M. Welch C. Redvanly Handbook of radiopharmaceuticals: radiochemistry and applications 2003 Wiley London 501 527
37. M. Strolin Benedetti, E. Frigerio, P. Tocchetti, G. Brianceschi, M. Castelli, and C. Pellizzoni Stereoselective and species-dependent kinetics of reboxetine in mouse and rat Chirality 7 1995 285 289
38. A. Biegon, and D. Samuel Binding of a labeled antidepressant to rat brain tissue Biochem Pharmacol 28 1979 3361 3366
39. 3H]-chlorpromazine to areas in the rat brain Eur J Pharmacol 51 1978 121 127
40. 3H]-desipramine in central nerve terminals studied with electron microscope autoradiography and subcellular fractionation Experientia 35 1979 1210 1212
41. D. Brunswick, S. Benmansour, S. Tejani-Butt, and M. Hauptmann Effects of high-dose methamphetamine on monoamine uptake sites in rat brain measured by quantitative autoradiography Synapse 11 1992 287 293
42. 18F]cyclofoxy and positron emission tomography J Cereb Blood Flow Metab 13 1993 24 42